Zusammenfassung
Die klinische Hyperthermic mit einer kontrollierten Temperaturerhöhung (40-44°C) im Zielgebiet wird in interdisziplinären onkologischen Behandlungskonzepten kombiniert mit Strahlen- und/oder Chemotherapie eingesetzt (Issels u. Falk 2001). Neben der direkten zytotoxischen Wirkung der Hyperthermic (Temperaturbereich > 42,5°c) besteht zusätzlich ein strahlen- und chemosensibilisierender sowie indirekt ein immunmodulatorischer Effekt im Hyperthermicrten Gewebe (Temperaturbereich 40-44°C).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amichetti M, Griaff C, Fellin G, Pani G, Bolner A, Maluta S, Valdagni R (1993) Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: a phase 1-11 study. Int J Radiation Oncology Biol Phys 26:801–807
Armour EP, McEachern D, Wang Z, Corry PM, Martinez A (1993) Sensitivity of human cells to mild hyperthermia. Cancer Res 53:2740–2744
Bauer KD, Henle KJ (1979) Arrhenius analysis of heat survival curves form normal and thermotolerant CHO cells. Radiation Res 78:251–263
Bornstein BA, Zouranjian PS, Hansen JL, Fraser SM, Gelwan LA, Teicher BA, Svensson GK (1992) Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma. Int J. Radiation Oncology Biol Phys 25:79–85
Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Hoff DD von (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413
Carter DL, MacFail JR, Clegg ST, Wan X, Prescott DM, Charles HC, Samulski TV (1998) Magnetic resonance thermometry during hyperthermia for human highgrade sarcoma. Int J Radiation Oncology Biol Phys 40:815–822
Dahl O (1994) Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E (eds). Hyperthermia and Oncology, vol IV. VSP, Utrecht, pp 9–28
Datta NR, Bose AK, Kapoor HK, Gupta S (1990) Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 6:479–486
Dewey WC (1994) Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 10:457–483
Emami B, Perez C, Leybovich L, Straube W, Gerichten D von (1987) Interstitial thermoradiotherapy in the treatment of malignant tumors. Int J Radiation Oncology Biol Phys 3:107–118
Emami B, Scott C, Perez CA et al. (1996) Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the radiation therapy oncology group. Int J Radiation Oncology Biol Phys 34:1097–1104
Feldmann HJ, Molls M, Krümpelmann S, Stuschke M, Sack H (1993) Deep regional hyperthermia: comparison between the annular phased array and the sigma-60 applicator in the same patients. Int J Radiation Oncology Biol Phys 26:111–116
Hahn GM, Ning SC, Elizaga M, Kapp DS, Anderson RL (1989) A comparison of thermal responses of human and rodent cells. Int J Radiation Biology 56:817–825
Hand JW, Hind AJ (1986) A review of microwave and RF applicators for localised hyperthermia. In: Hand JW, James JR (eds) Physical techniques in clinical hyperthermia. Research Studies Press, Letchworth Hertfordshire, pp 98–148
Haveman J, Rietbroek RC, Gererdink A, Rijn J van, Bakker PJM (1995) Effect of hyperthermia on the cytotoxicity of 2’,2’-difluorodeoxycytidine (gemcitabine) in cultered SW1573 cells. Int J Cancer 62:627–630
Hendrick JP, Hartl FU (1993) Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem 62:349–384
Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M (1987) Radiofrequency capacitive hyperthermia for deep-seated tumors. Cancer 60:128–135
Iliakis G, Seaner R, Okayasu R (1990) Effects of hyperthermia on the repair of radiation-induced DNA single-and double-strand breaks in DNA double-strand break repair-deficient-and repair-proficient cell lines. Int J Hyperthermia 6:813–833
Issels, RD, Abdel-Rahman, S, Wendtner et al. (2001) Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recur-rent high-risk soft tissue sarcomas (HR-STS) of adults: Long-term results of a phase II study. Eur J Cancer 37:1599–1608
Issels R, Falk M (2001) Hyperthermia in oncology. Int J Hyperthermia 17:1–18
Issels RD, Prenninger SW, Nagele A et al. (1990) Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. J Clin Oncol 8:1818–1829
Issels RD, Mittermüller I, Gerl A et al. (1991) Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients. Cancer J Res Clin Oncol 117:141–147
Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, Nakatsugawa S (1990) Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 6:719–740
Kampinga HH, Turkel-Uygur N, Roti JL, Konings AWT (1989) The relationship of increased nudear protein content induced by hyperthermia to killing of HeLa S3 cells. Radiat Res 117:511–522
Morimoto RA, Sarge KD, Abravaya K (1992) Transcriptional regulation of heat shock genes. A paradigm for inducible genomie responses. J Biol Chem 267:21987–21990
Multhoff G, Botzler C, Wiesnet M, Müller E, Meier T, Wilmanns W, Issels RD (1995) A stress-inducible 72-kDa heat shock protein (HSP72) is expressed of the surface of human tumor cells, but not on normal cells. Int J Cancer 61:272–279
Multhoff G, Botzier C, Jennen L, Schmidt J, Ellwart J, Issels R (1997) Heat shock protein 72 on tumor cells. A recognition structure for NK cells. J Immunol 158:4341–4350
Oleson JR, Samulski TV, Leopold KA, Scott TC, Dewhirst MW, Dodge RK, George SL (1993) Sensitivity of hyperthermia trialoutcomes to temperature and time: implications for thermal goals of treatment. Int J Radiation Oncology Biol Phys 25:289–297
Overgaard J (1989) The current and potential role ofhyperthermia in radiotherapy. Int J Radiation Oncology Biol Phys 16:535–549
Overgaard J, Gonzalez Gonzalez D, Hulshof MCCM, Arcangeli G, Dahl O, Mella O, Bentzen SM for European Society for Hyperthermic Oncology (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. The Lancet 345:540–543
Peller M, Löffler R, Baur A et al. (1999) MRT-gesteuerte regionale Tiefen Hyperthermic. Radiologe 39:756–763
Perez CA, Gillespie B, Pajak T, Horback NB, Emami B, Rubin P (1989) Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome. a report by the Radiation Therapy Oncology Group. Int J Radiation Oncology Biol Phys 16:551–558
Perez CA, Pajak T, Emami B, Hornback NB., Tupchong L, Rubin P (1991) Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Am J Clin Oncol 14:133–141
Petrovich Z, Langholz B, Gibbs FA et al. (1989) Regional hyperthermia for advanced tumors: a clinical study of 353 patients. Int J Radiation Oncology Biol Phys 16:601–607
Rau B, Wust P, Hohenberger P et al. (1998) Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. A phase II clinical trial. Annal of Surgery 227:380–289
Rietbroek RC, Schilthuis MS, Bakker PJM et al. (1997) Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79:935–942
Romanowski R, Schött C, Issels R et al. (1993) Regionale Hyperthermie mit systemischer Chemotherapie bei Kindern und Jugendlichen: Durchführbarkeit und klinische Verläufe bei 34 intensiv vorbehandelten Patienten mit prognostisch ungünstigen Tumorerkrankungen. Klin Pädiatr 205:249–256
Sapareto SA, Dewy WC (1984) Thermal dose determination in cancer therapy. Int J Radiation Oncology Biol Phys 10:787–800
Shibamoto Y, Nishimura Y, Abe M (1996) Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer. Hepato-Gastroenterology 46:326–332
Sneed PK, Stauffer PR, McDermott MW et al. (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiation Oncology Biol Phys 40:287–295
Streffer C. (1995) Molecular and cellular mechanisms of hyperthermia. In. Seegenschmiedt MH, Fessenden P, Vernon CC (eds) Thermoradiotherapy and thermocheotherapy. Springer, Berlin Heidelberg New York Tokyo, S 47–74
Sugimachi K, Kitamura K, Baba K, Ikebe M, Morita M, Matsuda H, Kuwano H (1992) Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus-A prospective randomized trial. Int J Hyperthermia 8:289–295
Sugimachi K, Kuwano H, Ide H, Toge T, Saku M, Oshiumi Y (1994) Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 10:485–493
Tamura Y, Peng P, Liu K, Daou M, Srivastava PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278:117–120
Towle LR (1994). Hyperthermia and drug resistance. In. Urano M, Douple E (eds) Hyperthermia and oncology, vol IV, VSP, pp 91–
Urano M, Kuroda M, Nishimura Y (1999) For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 15:79–107
Valdagni R, Amichetti M, Pani G (1988) Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiation Oncology Biol Phys 15:13–24
Valdagni R, Amichetti M (1993) Report of long-term followup in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiation Oncology Biol Phys 28:163–169
Vaupel P (1990) Pathophysiological mechanisms of hyperthermia in cancer therapy. In. Gautherie M (ed) Biological basis of oncologic thermotherapy. Springer, Berlin Heidelberg New York Tokyo, pp 74–134
Vaupel PW, KeHeher DK (1995) Metabolic status and reaction to heat of normal and tumor tissue. In: Seegenschmiedt MH, Fessenden P, Vernon CC (eds) Thermoradiotherapy and thermocheotherapy. Springer, Berlin Heidelberg new York Tokyo, pp 157–176
Vernon CC, van der Zee J, Liu FF (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiation Oncology Biol Phys 35:731–744
Wells AD, Malkovskky M (2000) Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today 21:129–132
Wendtner, CM, Abdel-Rahman, S, Baumert, J et al. (2001) Treatment of primary, recurrent or inadequately resected high-risk soft tissue sarcomas (HR-STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur. J. Cancer 37:1609–1616
Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U (1998) Hyperthermia for the treatment of patients with malignant germ cell tumors. A phase IIII study in ten children and adolescents with recurrent or refractory tumors. Cancer 82:793–800
Zee J van, Gonzalez Gonzalez D, Rhoon GC van, Dijk JD van, Putten WL van, Hart AA (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:119–125
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schlemmer, M., Abdel-Rahman, S., Issels, R.D. (2003). Hyperthermie. In: Boese-Landgraf, J., Gallkowski, U., Layer, G., Schalhorn, A. (eds) Regionale Tumortherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55839-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-55839-9_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62602-9
Online ISBN: 978-3-642-55839-9
eBook Packages: Springer Book Archive